Urinary Detection Times and Excretion Profiles of Clonazepam and 7‐Aminoclonazepam After a Single Oral Dose

Clonazepam (CLO) is a widely prescribed benzodiazepine also commonly encountered in forensic casework. However, the urinary excretion patterns of CLO and 7‐amino‐clonazepam (7‐amino‐CLO) have not been fully characterized in humans, warranting further investigation to improve interpretation of forensic toxicological findings. The main objectives of this study were to validate a UHPLC–MS/MS method to quantitate CLO and 7‐amino‐CLO in urine, and characterize urinary excretion profiles and detection windows of these analytes following controlled dosing. Volunteers ( n = 18) received a single oral dose of either 0.5 or 2.0 mg of Iktorivil, with urine samples collected pre‐dose, at 2, 4, 6, 8, 10, 12, 14, and 24 h on Day 1, and once daily on Days 2–6, 10, and 14 (i.e., 48, 72, 96, 120, 144, 240, 336 h post‐dose). The UHPLC–MS/MS method achieved a sensitive lower limit of quantitation (0.25 μg/L) and met all validation acceptance criteria. Mean creatinine‐corrected C max for the 0.5‐mg group were 4.8 ± 0.9 ng/mg for CLO and 31.0 ± 2.3 ng/mg for 7‐amino‐CLO, compared with 16.1 ± 3.0 ng/mg and 114.4 ± 13.6 ng/mg, respectively, for the 2.0‐mg group. Detection times for 7‐amino‐CLO were approximately three to four times longer than CLO for both groups. Immunoassay failed to detect all low‐dose cases, even with measurable 7‐amino‐CLO. These findings demonstrate the limitations of immunoassays for detecting low‐dose CLO exposure and underscore the importance of targeted testing (i.e., GC–MS/LC–MS) for CLO and 7‐amino‐CLO in drug‐facilitated crime investigations when CLO exposure is suspected, regardless of the immunoassay result.

Authors

Institutions

Publication Details

Journal
Drug Testing and Analysis
Published
2026-11-19
DOI
https://doi.org/10.1002/dta.70197
Primary Topic
Forensic Toxicology and Drug Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Urinary Detection Times and Excretion Profiles of Clonazepam and 7‐Aminoclonazepam After a Single Oral Dose

Robert Kronstrand, Fredrik C. Kugelberg, Linda Brinkhagen, Ingrid Nyström et al.
Drug Testing and Analysis
Forensic Toxicology and Drug Analysis
article

Urinary Detection Times and Excretion Profiles of Clonazepam and 7‐Aminoclonazepam After a Single Oral Dose

Robert Kronstrand, Fredrik C. Kugelberg, Linda Brinkhagen, Ingrid Nyström, Malin Forsman, Michael T Truver, Munchelou M Gomonit, Charlotte Brage
article en

Abstract

Clonazepam (CLO) is a widely prescribed benzodiazepine also commonly encountered in forensic casework. However, the urinary excretion patterns of CLO and 7‐amino‐clonazepam (7‐amino‐CLO) have not been fully characterized in humans, warranting further investigation to improve interpretation of forensic toxicological findings. The main objectives of this study were to validate a UHPLC–MS/MS method to quantitate CLO and 7‐amino‐CLO in urine, and characterize urinary excretion profiles and detection windows of these analytes following controlled dosing. Volunteers ( n = 18) received a single oral dose of either 0.5 or 2.0 mg of Iktorivil, with urine samples collected pre‐dose, at 2, 4, 6, 8, 10, 12, 14, and 24 h on Day 1, and once daily on Days 2–6, 10, and 14 (i.e., 48, 72, 96, 120, 144, 240, 336 h post‐dose). The UHPLC–MS/MS method achieved a sensitive lower limit of quantitation (0.25 μg/L) and met all validation acceptance criteria. Mean creatinine‐corrected C max for the 0.5‐mg group were 4.8 ± 0.9 ng/mg for CLO and 31.0 ± 2.3 ng/mg for 7‐amino‐CLO, compared with 16.1 ± 3.0 ng/mg and 114.4 ± 13.6 ng/mg, respectively, for the 2.0‐mg group. Detection times for 7‐amino‐CLO were approximately three to four times longer than CLO for both groups. Immunoassay failed to detect all low‐dose cases, even with measurable 7‐amino‐CLO. These findings demonstrate the limitations of immunoassays for detecting low‐dose CLO exposure and underscore the importance of targeted testing (i.e., GC–MS/LC–MS) for CLO and 7‐amino‐CLO in drug‐facilitated crime investigations when CLO exposure is suspected, regardless of the immunoassay result.

Drug Testing and Analysis
Linköping University (SE), Swedish National Board of Forensic Medicine (SE), University of Florida Health (US), University of Florida (US)
Forensic Toxicology and Drug Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon